#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cystic fibrosis lung Cutaneous T-cell lymphoma recurrent Anal fistula Chronic lymphocytic leukaemia recurrent Diffuse large B-cell lymphoma recurrent Polymyositis Myelofibrosis Thrombocytosis Hypergammaglobulinaemia benign monoclonal Chondrosarcoma metastatic Amyotrophic lateral sclerosis Alveolar proteinosis Adrenocortical carcinoma Acute hepatic failure Follicular lymphoma stage I More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Life with Disease Undifferentiated sarcoma Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Haemophagocytic lymphohistiocytosis – Diagnostics Bronchiolitis obliterans syndrome – Basic Information Mantle cell lymphoma stage III – Diagnostics Angiosarcoma – Basic Information Mucopolysaccharidosis II Waldenstrom’s macroglobulinaemia – Basic Information Lysosomal storage disorder – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pentixather Lasn01 S230815-2 Aminocaproic Acid Lenvatinib Methylprednisolone Aceponate RNK001 Azd8630 Tianeptine Sodium ADS-019 Interferon Beta-1A Divarasib Tovinontrine Disodium Levofolinate Gallium (68Ga) Gozetotide Fluconazole Ambrosia Artemisiifolia (302) Tapentadol Hydrochloride Paroxetine Hydrochloride Zilovertamab Vedotin More therapies…

    Learn about Your Condition

    Anxiety Underweight Marginal zone lymphoma Ventricular extrasystoles Frontotemporal dementia Femoral neck fracture Dyspnoea Cytomegalovirus infection Pleomorphic liposarcoma Castleman's disease Growth hormone deficiency Von Hippel-Lindau disease Uterine cancer Salivary gland cancer Bipolar disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study to evaluate the safety and effectiveness of budiodarone tartrate in patients with non-permanent atrial fibrillation

    Recruiting

    4 1 1 1
    Poland

  • A study to evaluate the safety and effectiveness of darizmetinib hydrochloride in patients who have had liver surgery due to colon cancer metastases

    Recruiting

    1 1
    Investigated Diseases:
    • Colon cancer stage III
    • Colon cancer
    France Germany Spain

  • A study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B

    Recruiting

    3 1 1
    Investigated Drugs:
    • Fidanacogene Elaparvovec
    • Giroctocogene Fitelparvovec
    France Germany Greece Italy Spain Sweden

  • A study to evaluate the efficacy and safety of trospium chloride and xanomeline tartrate for the treatment of schizophrenia in adolescents aged 13 to 17 years

    Recruiting

    3 1
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Romania

  • A study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis

    Recruiting

    2 1
    Investigated Drugs:
    • VAMIFEPORT TRIHYDROCHLORIDE
    Austria Belgium Czechia France Germany Ireland +5

  • A study to evaluate the safety and how pivekimab sunirine works in children with relapsed or refractory acute myeloid leukemia

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Pivekimab Sunirine
    Belgium Czechia France Hungary Italy Spain
Previous Page
1 … 27 28 29 30 31 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!